Importance Transgender and gender-diverse individuals face unique challenges, including
barriers to health care access and inequities in treatment, that may influence cancer risk and …

Abstract Context Approximately 0.4–1.3% of the worldwide population is transgender.
Although the exact prevalence is unknown, there is an increase in open identification as …

Preventive health care use can reduce the risk of disease, disability, and death. Thus, it is
critical to understand factors that shape preventive care use. A growing body of research …

Background The agony and economic strain of cancer and HIV/AIDS therapies severely
impact patients' psychological wellbeing. Meanwhile, sexual minorities experience …

There is a pressing need for greater understanding and focus on cancer survivorship and
informal cancer caring of trans people (binary and non-binary), across tumor types, to inform …

In recent history, immunotherapy has become a viable cancer therapeutic option. However,
over many years, its tenets have changed, and it now comprises a range of cancer-focused …

Introduction The 2018 US Preventive Services Task Force recommendations endorsed
shared decision making for men aged 55–69 years, encouraging consideration of patient …

Abstract Purpose of Review To systematically review the evidence on prostate cancer (PCa)
in transgender women (TGW). Recent Findings A total of 25 studies were included. Fourteen …

Objectives: The purpose of this scoping review was to identify the risk factors and screening
uptake for prostate cancer. Design: Scoping review. Methods: Arksey and O'Malley's …

Sexual and gender minorities (SGM) include persons identifying as lesbian, gay, bisexual,
transgender/non-binary, and queer experience a greater cancer burden than their …